Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.46M Hold
10,044
– – 0.67% 21
2026
Q2
$1.29M Sell
10,044
-15,868
-61% -$1.86M 0.59% 25
2026
Q1
$3.12M Sell
25,912
-3,348
-11% -$387K 1.05% 10
2025
Q4
$3.08M Buy
29,260
+10,970
+60% +$1.03M 0.95% 8
2025
Q3
$1.54M Buy
18,290
+9,289
+103% +$765K 0.51% 34
2025
Q2
$713K Buy
+9,001
New +$715K 0.28% 102

Other funds holding MRK

Essential Partners's MRK Position: Q3 2026 in Review

Essential Partners held its Merck (MRK) position steady in Q3 2026 at 10,044 shares worth $1.46M. The position accounts for 0.67% of the portfolio, ranked #21.

Essential Partners first reported a position in MRK in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.12M in Q1 2026. 682 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Essential Partners held 10,044 shares of Merck worth $1.46M as of Q3 2026.
  • Essential Partners left its Merck share count unchanged in Q3 2026.
  • Merck made up 0.67% of Essential Partners's portfolio in Q3 2026, its #21 holding.
  • Essential Partners first reported a position in Merck in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Merck position peaked at $3.12M in Q1 2026.
  • 682 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.